Healthcare Professionals Report an Adverse Event Contact Global (EN)
Home / Terms of Use

Terms of use

Last updated 1 July 2026.

Acceptance

By using this website you agree to these terms. If you do not agree, please do not use the site.

No medical advice

Content on this site is general information about our company and our research. It is not medical advice, does not create a doctor–patient relationship, and must never be used to diagnose or treat a health problem. Always speak to a qualified healthcare professional.

Product information and territory

Medicines are approved on a country-by-country basis. Information here may describe products or uses that are not approved where you live. Nothing on this site is an advertisement or promotion of a prescription medicine in any jurisdiction where that would be unlawful.

Forward-looking statements

Statements about our pipeline, plans and expected performance are forward-looking and subject to risks and uncertainties. Actual outcomes may differ materially.

Intellectual property

All content, trademarks and logos on this site are owned by Baxtra or its licensors. You may view and print pages for personal, non-commercial use. All other use requires written permission.

Third-party links

We provide links for convenience and are not responsible for third-party content or practices.

Submissions

Do not send confidential or proprietary information through this site. Unsolicited submissions are treated as non-confidential, except adverse event and privacy-related information, which we handle under our safety and privacy obligations.

Disclaimer and liability

The site is provided “as is” without warranties of any kind. To the fullest extent permitted by law, Baxtra is not liable for any loss arising from use of, or inability to use, this site.

Governing law

These terms are governed by the laws of the Commonwealth of Massachusetts, USA, without regard to conflict of laws principles.

Changes

We may update these terms; the “last updated” date will change accordingly.